Bayesian Capital Management, LP
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1632551
Brooklyn, NY
Position in TEVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$481,096
-$73,029 QoQ
Shares Held
14,200
-58.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#399
of 673 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bayesian Capital Management, LP holds $516,331 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (93.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
14,200 | $481,096 | |
| 2 | ORGO |
Organogenesis Holdings Inc.
|
14,500 | $35,235 |
All Filings in TEVA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $481,096 | 14,200 | Shares | Sole | 2026-08-14 | |
| 2024-06-30 | $554,125 | 34,100 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $347,805 | 39,300 | Shares | Sole | 2023-05-15 | |
| 2022-06-30 | $277,488 | 36,900 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $737,115 | 78,500 | Shares | Sole | 2022-05-16 | |
| 2021-03-31 | $365,818 | 31,700 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,193,705 | 123,700 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,183,013 | 131,300 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $752,130 | 61,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,357,776 | 151,200 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||